enGene Holdings Inc.

ENGN · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.5B · 82 employees
64
SEC Filings
$1.78
Close 2026-06-29
82
Employees

Business Summary

Competition for additional information. The genetic medicine field is relatively new and evolving rapidly. Because of our limited technical, financial and human resources, we are focusing our research and development efforts on detalimogene, as well as further development of our genetic medicine platform and other product candidates we may develop. As a result, we may forego or delay pursuit of other genetic medicine technologies or other therapeutic product candidates that provide significant a...

Latest Stock Quote

ENGN 2026-06-29 $1.78 O:$1.73 H:$1.8 L:$1.72 Vol:1.0M VWAP:$1.7669
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-12

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-12-222025-10-310001193125-25-328743EDGAR107K words
2024-12-192024-10-310000950170-24-138472EDGAR
2024-01-292023-10-310000950170-24-008125EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-03-092026-01-310001193125-26-097541EDGAR24K words
2025-09-112025-07-310000950170-25-114224EDGAR
2025-06-122025-04-300000950170-25-085143EDGAR
2025-03-102025-01-310000950170-25-036281EDGAR
2024-09-102024-07-310000950170-24-105180EDGAR
2024-06-142024-04-300000950170-24-073330EDGAR
2024-03-112024-01-310000950170-24-029413EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-110001193125-26-344559EDGAR
2026-07-170001193125-26-307795EDGAR
2026-07-160001193125-26-305418EDGAR
2026-03-090001193125-26-097546EDGAR26K words
2026-03-090001193125-26-097534EDGAR
2026-01-210001193125-26-017945EDGAR
2026-01-210001193125-26-017226EDGAR
2025-12-220001193125-25-328706EDGAR
2025-11-140001193125-25-283182EDGAR
2025-11-120001193125-25-275722EDGAR

64 total filings indexed. 44 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Company Identity

CIK0001980845
TickerENGN
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedZ4
Websitehttps://www.engene.com
Listed2023-11-01

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: fd199852b96dc83e255ec09ef67fe14cb9c426f06bfa8d1b42c30098d10c10d5
parent: 4072bdb16acf917288cc5e9ed171f330399779757e150e39deafe3d76ba53537
content hash: 5f20aabac2bb94eabe66596efa2a1ab48e1ee3d55edefef5034e4a1e43d1541d
signed: 2026-08-12T19:02:32.699Z
sources: 10 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up ENGN using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on ENGN, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/ENGN (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.